Chronic Cough Market Report 2026

Chronic Cough Market Overview

• Chronic Cough market size has reached to $8.87 billion in 2025 • Expected to grow to $14.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Smoking Epidemic Fuels Surge In Chronic Cough Cases Is A Catalyst For Growth In The Chronic Cough Market • Market Trend: Innovative Product Developments Transforming The Landscape Of The Chronic Cough Market • North America was the largest region in 2025.

What Is Covered Under Chronic Cough Market?

Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections. The main chronic cough drug class types are antihistamines, corticosteroids, decongestants, combination drug, antibiotics, acid blockers, and others. Antihistamines refers to a group of medications intended to treat allergies caused by histamines' physiological effects. The various routes of administration are oral, inhalational, injectable, and others used in hospitals, homecare, specialty centers, and others. The distribution channels are hospital pharmacy, online pharmacy, and retail pharmacy.

What Is The Chronic Cough Market Growth Forecast?

The chronic cough market size is expected to see strong growth in the next few years. It will grow to $14.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing focus on personalized respiratory treatments, rising investments in novel cough therapeutics, growing demand for non-opioid cough suppressants, expansion of telehealth-based respiratory care, increasing emphasis on long-term symptom management. Major trends in the forecast period include increasing development of targeted antitussive therapies, rising focus on combination drug formulations, growing adoption of long-acting cough suppressants, expansion of acid reflux-linked cough treatments, enhanced emphasis on differential diagnosis approaches.

Global Chronic Cough Market Segmentation

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes 2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route Of Administrations 3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users Subsegments: 1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines 2) By Corticosteroids: Inhaled Corticosteroids, Systemic Corticosteroids 3) By Decongestants: Oral Decongestants, Nasal Decongestants 4) By Combination Drug: Antihistamine And Decongestant Combinations, Cough Suppressant And Expectorant Combinations 5) By Antibiotics: Macrolides, Penicillins, Cephalosporins 6) By Acid Blockers: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists 7) By Other Drug Classes: Mucolytics, Cough Suppressants, Herbal Remedies

What Is The Driver Of The Chronic Cough Market?

The increasing prevalence of smoking and tobacco consumption is expected to propel the growth of the chronic cough market going forward. Smoking is a practice in which a substance, typically tobacco, is burned, and the resulting smoke is inhaled or absorbed into the bloodstream. Smoking and tobacco consumption causes irritation of airways, chronic bronchitis, increased mucus production, reduced lung function, weakening of immune system, interference with cough reflex, and risk of lung cancer. For instance, In October 2024, According to The Office for National Statistics (ONS), UK-Based, government department, in 2023, approximately 6.0 million adults in the UK, representing 11.9% of the population aged 18 and over, were cigarette smokers. Therefore, the increasing prevalence of smoking and tobacco consumption is driving the growth of the chronic cough industry.

Key Players In The Global Chronic Cough Market

Major companies operating in the chronic cough market are Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

Global Chronic Cough Market Trends and Insights

Major companies operating in the chronic cough market are concentrating on creating innovative products such as biosimilar to strengthen their position in the market. Biosimilars are used to treat conditions like cancer, autoimmune diseases, and diabetes, offering cost-effective alternatives to existing biologics. For instance, in July 2024, according to the Sandoz, a Switzerland-based Pharmaceutical company, launched its biosimilar Pyzchiva (ustekinumab) across Europe, targeting chronic inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and Crohn's disease. This biosimilar is particularly significant as it is the first of its kind available in Europe with all reference medicine strengths, including the initiation dose for Crohn's disease. Developed in partnership with Samsung Bioepis, Sandoz aims to enhance access to effective treatments for millions affected by these conditions. The launch reflects Sandoz's commitment to providing affordable healthcare solutions and improving the quality of life for patients across Europe.

What Are Latest Mergers And Acquisitions In The Chronic Cough Market?

In June 2023, GSK Plc., a UK-based global healthcare company, acquired BELLUS Health, for an undisclosed amount. With this acquisition, GSK aims to strengthen its rare disease portfolio, accelerate the development and commercialization of innovative therapies, and expand its presence in the global specialty pharmaceutical market. BELLUS Health is a Canada-based clinical-stage biopharmaceutical company, that offers chronic cough treatments.

Regional Outlook

North America was the largest region in the chronic cough market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Cough Market?

The chronic cough market consists of revenues earned by entities by providing services such as chest X-ray or CT scan services, lung function tests, and sputum culture. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic cough market also includes sales of cough suppressants, expectorants, inhalers, and allergy medications which are used in providing the services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Cough Market Report 2026?

The chronic cough market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic cough industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.